Fuller & Thaler Asset Management, Inc. Amgen Inc Transaction History

Fuller & Thaler Asset Management, Inc.

$25 Billion
Q3 2024

A detailed history of Fuller & Thaler Asset Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Fuller & Thaler Asset Management, Inc. holds 32,739 shares of AMGN stock, worth $8.62 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

32,739

Previous 18,614 75.88%

Holding current value

$8.62 Million

Previous $5.82 Million 81.39%

% of portfolio

0.04%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $4.37 Million - $4.77 Million	14,125 Added 75.88%	32,739 $10.5 Million
Q2 2024 Aug 09, 2024	BUY	$262.75 - $319.31 $332,641 - $404,246	1,266 Added 7.3%	18,614 $5.82 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $1.29 Million - $1.55 Million	4,785 Added 38.09%	17,348 $4.93 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $231,408 - $261,056	905 Added 7.76%	12,563 $3.62 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $42,199 - $52,391	193 Added 1.68%	11,658 $3.13 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $265,480 - $313,925	1,239 Added 12.12%	11,465 $2.55 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $30,707 - $37,427	-136 Reduced 1.31%	10,226 $2.47 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $438,821 - $557,575	-1,916 Reduced 15.61%	10,362 $2.72 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $1.27 Million - $1.44 Million	-5,670 Reduced 31.59%	12,278 $2.77 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $1.55 Million - $1.73 Million	-6,740 Reduced 27.3%	17,948 $4.37 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $112,485 - $124,438	513 Added 2.12%	24,688 $5.97 Million
Q4 2021 Feb 09, 2022	SELL	$198.88 - $227.6 $589,480 - $674,606	-2,964 Reduced 10.92%	24,175 $5.44 Million
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $346,212 - $405,629	-1,631 Reduced 5.67%	27,139 $5.77 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $99,271 - $110,134	425 Added 1.5%	28,770 $7.01 Million
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $489,089 - $569,954	2,204 Added 8.43%	28,345 $7.05 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $291,031 - $346,566	1,345 Added 5.42%	26,141 $6.01 Million
Q3 2020 Nov 09, 2020	BUY	$234.65 - $260.95 $248,729 - $276,607	1,060 Added 4.47%	24,796 $6.3 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $2.26 Million - $2.78 Million	11,436 Added 92.98%	23,736 $5.6 Million
Q1 2020 May 06, 2020	BUY	$182.24 - $241.7 $2.24 Million - $2.97 Million	12,300 New	12,300 $2.49 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $737,454 - $831,382	-3,980 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $576,062 - $673,200	-3,400 Reduced 46.07%	3,980 $679,000
Q3 2017 Nov 08, 2017	SELL	$167.29 - $191.0 $267,664 - $305,600	-1,600 Reduced 17.82%	7,380 $1.38 Million
Q2 2017 Aug 14, 2017	BUY	N/A	8,980	8,980 $1.55 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.

Account

Fuller & Thaler Asset Management, Inc. Amgen Inc Transaction History